loading...| Preferred Name |
Etonogestrel |
|
| Synonyms |
ETONOGESTREL (17-alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one Etonogestrel 3-Keto-Desogestrel Implanon |
|
| Definitions |
A synthetic form of the naturally occurring female sex hormone progesterone. Etonogestrel binds to the cytoplasmic progesterone receptors in the reproductive system and subsequently activates progesterone receptor mediated gene expression. As a result of the negative feedback mechanism, luteinizing hormone (LH) release is inhibited, which leads to an inhibition of ovulation and an alteration in the cervical mucus and endometrium. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47528 |
|
| CAS_Registry |
54048-10-1 |
|
| CHEBI_ID |
CHEBI:50777 |
|
| Chemical_Formula |
C22H28O2 |
|
| code |
C47528 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
A synthetic form of the naturally occurring female sex hormone progesterone. Etonogestrel binds to the cytoplasmic progesterone receptors in the reproductive system and subsequently activates progesterone receptor mediated gene expression. As a result of the negative feedback mechanism, luteinizing hormone (LH) release is inhibited, which leads to an inhibition of ovulation and an alteration in the cervical mucus and endometrium. |
|
| FDA_UNII_Code |
304GTH6RNH |
|
| FULL_SYN |
ETONOGESTREL (17-alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one Etonogestrel 3-Keto-Desogestrel Implanon |
|
| label |
Etonogestrel |
|
| Legacy Concept Name |
Etonogestrel |
|
| Preferred_Name |
Etonogestrel |
|
| prefixIRI |
Thesaurus:C47528 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0047683 |
|
| subClassOf |